Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 26, 2024 • 6:01 PM ET

Date/Time Source News Release
11/25/2024 04:05 PM EST GlobeNewswire Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business Update
11/28/2023 07:00 AM EST GlobeNewswire Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
02/07/2019 03:18 PM EST GlobeNewswire Nasdaq Welcomes Alector, Inc. (Nasdaq: ALEC) to the Nasdaq Stock Market
Page
  • 1

Additional News

As of November 26, 2024 • 6:01 PM ET

Date/Time Source News Release
11/26/2024 05:04 AM EST SeekingAlpha Biggest stock movers Tuesday: PSTX, SMTC, ALEC, LESL, WWD and more
11/25/2024 04:45 PM EST SeekingAlpha Alector drops 31% as Alzheimer's candidate fails in phase 2 trial
11/19/2024 05:00 PM EST KlickAnalytics ALEC Price Target Alert: $4.00. Issued by Goldman Sachs
12/05/2023 09:55 AM EST Zacks Wall Street Analysts Think Alector (ALEC) Could Surge 142.53%: Read This Before Placing a Bet
11/14/2023 09:35 AM EST Zacks Alector (ALEC) Loses -38.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
02/09/2019 11:13 AM EST SeekingAlpha U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
02/07/2019 02:40 AM EST SeekingAlpha Alector prices IPO at $19
Page
  • 1